NVNOW Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	24 254
Vidutinė apimtis	8 352
Rinkos kapitalizacija	63.58M
EPS	$-0.310 ( Q1 \| 2024-05-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0.0120 (190.48%)

ABMD 0.00%

AMIX -4.95%

BBLGW -21.85%

BVS 0.52%

COCH 3.06%

DHAI -3.26%

DHAIW -22.93%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -1.70%

HSCSW -32.26%

IINNW 1.61%

INVO -3.33%

LFWD 1.26%

MDAI -2.22%

MGRM 3.86%

MXCT -2.00%

NVNOW -32.98%

NXL -42.91%

NXLIW -15.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 0.00%

PETVW 0.00%

QTI 2.21%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-12-05	Glynn Craig	Buy	75 000	Stock Options
2023-12-05	Jenusaitis Matthew	Buy	13 856	Stock Options
2023-12-05	Alavi Hamed	Buy	100 000	Stock Options
2023-12-05	Glickman Marc H.	Buy	100 000	Stock Options
2023-12-05	Gray Robert	Buy	13 856	Stock Options

INSIDER POWER
51.32
Last 96 transactions
Buy: 7 138 437 \| Sell: 4 126 509

Tūris Koreliacija

Ilgas: -0.36 (neutral)

Trumpas: 0.00 (neutral)

Signal:(34.031) Neutral

enVVeno Medical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

enVVeno Medical Koreliacija - Valiuta/Žaliavos

0.58
( weak )

-0.57
( weak negative )

0.00
( neutral )

0.43
( neutral )

0.00
( neutral )

-0.38
( neutral )

enVVeno Medical Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2023
Pajamos:	$0
Bruto pelnas:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2022
Pajamos:	$0
Bruto pelnas:	$-525 000 (0.00 %)
EPS:	$-2.16

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-1.904

Financial Reports:

No articles found.

enVVeno Medical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

enVVeno Medical

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company\'s lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.